ERMONDI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 5.542
EU - Europa 4.449
AS - Asia 1.498
AF - Africa 77
SA - Sud America 20
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.602
Nazione #
US - Stati Uniti d'America 5.462
IT - Italia 773
DK - Danimarca 725
CN - Cina 630
SE - Svezia 588
IE - Irlanda 492
DE - Germania 443
UA - Ucraina 285
FR - Francia 248
FI - Finlandia 236
SG - Singapore 215
KR - Corea 202
GB - Regno Unito 193
VN - Vietnam 171
IN - India 153
PL - Polonia 140
AT - Austria 99
CA - Canada 67
SN - Senegal 60
JP - Giappone 44
BE - Belgio 39
ES - Italia 38
RU - Federazione Russa 37
CH - Svizzera 29
NL - Olanda 24
HK - Hong Kong 22
PT - Portogallo 22
BR - Brasile 11
IR - Iran 11
AU - Australia 10
ID - Indonesia 10
RO - Romania 10
TW - Taiwan 10
MX - Messico 8
DZ - Algeria 7
GR - Grecia 7
EU - Europa 5
HU - Ungheria 5
MY - Malesia 5
NO - Norvegia 5
ZA - Sudafrica 5
CR - Costa Rica 4
TH - Thailandia 4
CL - Cile 3
IQ - Iraq 3
PK - Pakistan 3
TR - Turchia 3
BD - Bangladesh 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
EE - Estonia 2
EG - Egitto 2
IL - Israele 2
LT - Lituania 2
MD - Moldavia 2
NG - Nigeria 2
PH - Filippine 2
UY - Uruguay 2
UZ - Uzbekistan 2
AM - Armenia 1
AR - Argentina 1
CO - Colombia 1
GE - Georgia 1
HR - Croazia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PA - Panama 1
SA - Arabia Saudita 1
SM - San Marino 1
TN - Tunisia 1
Totale 11.602
Città #
Ann Arbor 887
Chandler 684
Dublin 487
Beijing 427
Houston 306
Fairfield 288
Torino 278
Ashburn 243
Wilmington 213
Jacksonville 173
Nyköping 165
Princeton 155
Woodbridge 155
Medford 143
Singapore 140
Stockholm 140
Dearborn 133
Dong Ket 133
Villeurbanne 133
Warsaw 126
Seattle 113
Cambridge 98
Vienna 94
Pisa 80
Pune 76
Boston 75
Milan 67
Redwood City 65
Turin 65
Los Angeles 55
Boardman 51
Fremont 40
San Diego 36
Brussels 31
Hangzhou 30
Washington 30
Munich 28
Norwalk 27
Falls Church 25
Verona 24
Guangzhou 21
Nanjing 19
New York 19
Seoul 19
Toronto 19
Barcelona 18
Lachine 18
Philadelphia 18
Santa Cruz 18
Höst 16
Zurich 16
Santa Clara 15
Helsinki 13
London 13
Chennai 12
Duncan 12
Düsseldorf 12
Hebei 12
Hyderabad 12
Phoenix 12
Grafing 11
Rome 11
Newbury Park 10
Nürnberg 10
Shanghai 10
Paris 9
Piemonte 9
Groningen 8
Hefei 8
Hong Kong 8
Montréal 8
Auburn Hills 7
Bend 7
Carrara 7
Chengdu 7
Des Moines 7
Kunming 7
Mountain View 7
Mumbai 7
Palaiseau 7
Taipei 7
Aldie 6
Amsterdam 6
Central District 6
Chicago 6
Uppsala 6
Bengaluru 5
Castro Daire 5
Clifton 5
Cumiana 5
Jinan 5
Madrid 5
Nottingham 5
Novi Ligure 5
Rho 5
San Francisco 5
Tokyo 5
Vancouver 5
Ashtead 4
Bologna 4
Totale 7.103
Nome #
Prediction and interpretation of the lipophilicity of small peptides 314
Lipophilicity of amyloid β-peptide 12-28 and 25-35 to unravel their ability to promote hydrophobic and electrostatic interactions 231
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents. 229
Log P in the bRo5 chemical space 223
Multivariate analysis applied to Raman mapping of dye-functionalized carbon nanotubes: A novel approach to support the rational design of functional nanostructures 220
Managing Experimental 3D Structures in the Beyond-Rule-of-5 Chemical Space: The Case of Rifampicin 217
The Block Relevance (BR) analysis supports the dominating effect of solutes hydrogen bond acidity on Δlog Poct–tol 216
Application of in silico classical drug discovery tools for peptide research 210
Blended-learning for courses in Pharmaceutical Analysis 208
A Fast Chromatographic Method for Estimating Lipophilicity and Ionization in Nonpolar Membrane-Like Environment 205
Log P as a tool in intramolecular hydrogen bond considerations 205
Profile of the intermolecular forces governing the interaction of drugs with mucin 202
APPLICATION OF IN-SILICO "CLASSICAL" DRUG DISCOVERY TOOLS TO PEPTIDE RESEARCH 199
SYNTHESIS, LIPOPHILICITY AND PERMEABILITY OF CYCLIC HEXAPEPTIDES AS MODELS TO DISCOVER NEW CELL PENETRATING PEPTIDES (CPPS) 189
1,4-Dihydropyridines containing R-NNO-azoxy moieties 188
Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridine Ca2+-antagonists 184
A New Synthetic Approach to Substituted β-Carboline Systems 183
Carbon Nanotubes modified with organic dyes: synthesis and characterization 181
A kinetic study of the interaction between potential photosensitizers and albumin 175
IAM chromatography: information provided and relevance in the prediction of permeability 165
Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry 154
Charged cyclic hexapeptides: Updating molecular descriptors for permeability purposes 149
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer candidates and cyclodextrins 145
Relating Caco-2 permeability to molecular properties using block relevance analysis 138
Experimental validation of in silico methods to predict the recognition properties of active sites: the test-case of a non-heme iron dioxygenase 136
Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs beyond the Rule of 5 131
Learning how to use IAM chromatography for predicting permeability 122
The Block Relevance (BR) analysis to aid medicinal chemists to determine and interpret lipophilicity 121
Efficient microwave-assisted synthetic protocols and in silico behaviour prediction of per-substituted β-cyclodextrins 113
HT Caco-2 permeability: the dominant role played by solutes’ hydrogen bonding donor properties 108
Ligand-based design, in silico ADME-Tox filtering, synthesis and biological evaluation to discover new soluble 1,4-DHP-based CFTR activators 104
An NMR relaxation study of aqueous solutions of Gd(III) chelates 102
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 102
Molecular interaction fields based descriptors to interpret and compare chromatographic indexes 101
IκBα targeting promotes oxidative stress-dependent cell death 100
A free web application for sharing resources about cyclodextrin/ligand complexes 99
High throughput methods to measure the propensity of compounds to form intramolecular hydrogen bonding 99
Physico-chemical characterization, permeability and molecular dynamics simulations of two series of structurally related macrocycles 97
Blended-learning for courses in Pharmaceutical Analysis. Part 2 97
GRID/BIOCUBE4mf to rank the influence of mutations on biological processes to design ad hoc mutants 96
Lipophilicity, polarity and hydrophobicity 95
Umbelliferone Aminoalkyl Derivatives asInhibitors of Human Oxidosqualene: Lanosterol Cyclase 93
www.cdtec.unito.it: a web platform for scientists involved with cyclodextrins-related topics 91
Do surface-based match solution-based techniques? the case of drug-liposome interaction 91
An application of two MIFs-based tools (Volsurf+ and Pentacle) to binary QSAR: The case of a palinurin-related data set of non-ATP competitive Glycogen Synthase Kinase 3b (GSK-3b) inhibitors 90
Block relevance (BR) analysis and polarity descriptors in property-based drug design 90
A computational strategy to predict recognition and catalysis on recalcitrant chlorinated substrates by a catechol1,2 dioxygenase. 86
Lead discovery and synthesis of selective T-type calcium channel blockers 85
Predicting the Permeability of Macrocycles from Conformational Sampling – Limitations of Molecular Flexibility 84
HIGHLY EFFICIENT SYNTHESIS AND IN SILICO CHEMICAL SCREENING OF PER-SUBSTITUTED CYCLODEXTRINS 80
BR ANALYSIS: A TOOL TO UNRAVEL MOLECULAR INTERACTIONS BALANCE 79
AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/Alsin 79
Benzofurazanyl- and benzofuroxanyl-1,4-dihydropyridines: Synthesis, structure and calcium entry blocker activity 78
Unsymmetrically substituted furoxants. 17. Structural investigations in benzenesulfonylfuroxan derivatives and related compounds 77
A combined in silico strategy to describe the variation of some 3D molecular properties of β-cyclodextrin due to the formation of inclusion complexes 77
Docking studies on NSAID/COX-2 isozyme complexes using Contact Statistics analysis 76
Synthesis and structural characterization of the trimeric furoxan (equals furazan 2-oxide) system, a new potent vasodilating moiety 76
Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridines Ca2+-agonists 76
Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations? 76
Unsymmetrically substituted furoxans. Part 16 [1]. Reaction of benzenesulfonyl substituted furoxans with ethanol and ethanethiol in basic medium 73
Exploring the access of the substrate to the active site of yeast oxidosqualene cyclase by site-directed mutagenesis 73
New 1,4-Dihydropyridines Conjugated to Furoxanyl Moieties, endowed With both NO-like and Ca2+ Channel Antagonist Vasodilator Activities 72
Exploring the access of the substrate to the active site of yeast oxidosqualene cyclase by site-directed mutagenesis. 72
Synthesis and NMRD studies of gadolinium(3+) complexes of macrocyclic polyamino polycarboxylic ligands bearing .beta.-benzyloxy-.alpha.-propionic residues 71
ZWITTERIONS IN DRUG DISCOVERY: STUDIES OF THE TAUTOMERIC EQUILIBRIUM WITH IN-SILICO AND EXPERIMENTAL TOOLS 71
Experimental lipophilicity for beyond Rule of 5 compounds 71
A Molecular-Modeling Approach to Understanding the Contributions Made by Ionization and Lipophilicity to Drug Binding to Albumin 70
The Relevance of Polar Surface Area (PSA) in Rationalizing Biological Properties of Several cis-Diamminemalonatoplatinum(II) Derivatives 70
Molecular descriptors for polarity: The need for going beyond polar surface area 70
Furoxans as Nitric Oxide Donors. 4-Phenyl-3-furoxancarbonitrile: Thiol-Mediated Nitric Oxide Release and Biological Evaluation 69
Characterization of the Channel Constriction Allowingthe Access of the Substrate to the Active Site of YeastOxidosqualene Cyclase 69
The use of Web resources to share information about cyclodextrins 67
Access of the substrate to the active site of yeast oxidosqualene cyclase: a modelling and site-directed mutagenesis approach 67
Are we ready to design oral PROTACs®? 67
Structural Investigation of Ca2+ Antagonist Benzofurazanyl and Benzofuroxanyl 1,4-Dihydropyridines 66
A comparison of calculated and experimental parameters as a source of structural information: the case of lipophilicity related descriptors 66
Thermolysis of 4-(2-azido-3-nitrophenyl)-1,4-dihydropyridines as source of beta-carboline derivatives and some related compounds 64
NMR study of solution structures and dynamics of lanthanide(III) complexes of DOTA 63
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents (Scientific Reports, (2019), 9, 1, (3089), 10.1038/s41598-019-39510-w) 63
Structure properties relations in the basicity and lipophilicity of arylalkylamine oxides 62
On the complexation of Trolox with methyl-beta-cyclodextrin: characterization, molecolar modelling and photostabilizing properties 61
Molecular and statistical modeling of reduction peak potentialand lipophilicity of platinum(IV) complexes 60
BIOCUBE4mf 58
LC-FTMS of platinum complex antineoplastic drugs 58
Paramagnetic water proton relaxation enhancement: From contrast agents in MRI to reagents for quantitative “in vitro” assays 57
Dall’intelligenza artificiale nuove prospettive per la ricerca sulle malattie rare 57
Determination of metal–proton distances and electronic relaxation times in lanthanide complexes by nuclear magnetic resonance spectroscopy 54
Rational Control of Molecular Properties Is Mandatory to Exploit the Potential of PROTACs as Oral Drugs 54
NMR studies of macrocylic lanthanide(III) complexes 52
MLR, PLSR-BR Analysis and MBPLSR to Interpret Multivariate QSPR Models. The Case of a Micellar Liquid Chromatography Descriptor (log K WSDS ) 52
Synthesis, characterization, structure, molecular modeling studies and biological activity of sterically crowded Pt(II) complexes containing bis(imidazole) ligands 51
Relaxometric, Structural, and Dynamic NMR Studies of DOTA-like Ln(III) Complexes (Ln = La, Gd, Ho, Yb) Containing a p-Nitrophenyl Substituent 47
Relationship between passive permeability and molecular polarity using block relevance analysis 46
OpenCDLig 45
Structural characterization of GSK-3b by in silico tools: a crucial step towards the design of selective non-ATP competitive inhibitors 45
Why we need to implement intramolecular hydrogen-bonding considerations in drug discovery 45
Characterization of the new CelerisTM Arginine column: Retentive behaviour through a combination of chemometric tools and potential in drug analysis 45
Development of molecular hydrogen-bonding potentials (MHBPs) and their application to structure–permeation relations1 44
The 1,2-dichloroethane/water vs the n-octanol/water system: more about intra- or intermolecular H-bond interactions 44
Pyrazole analogues of prazosin 44
Totale 10.492
Categoria #
all - tutte 32.876
article - articoli 0
book - libri 0
conference - conferenze 7.898
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.774


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.062 0 53 150 147 195 322 254 188 250 206 132 165
2020/20211.431 190 60 122 50 100 72 100 48 199 102 66 322
2021/20222.018 175 118 105 193 131 127 128 148 92 140 311 350
2022/20232.199 258 166 88 218 149 588 201 114 200 46 109 62
2023/20241.067 110 139 73 66 76 164 19 91 9 96 71 153
2024/2025273 38 235 0 0 0 0 0 0 0 0 0 0
Totale 12.091